LXRX LEXICON PHARMACEUTICALS INC Earnings Reports 8-K Filing 2024 - Earnings Report LEXICON PHARMACEUTICALS INC reported a net loss of $25.6 million for the third quarter of 2023, with total revenue of $3.5 million, primarily from collaborations and grants.Get access to all SEC 8-K filings of the LEXICON PHARMACEUTICALS INC